*CLOSED TO RECRUITMENT*

  1. SUB-TYPE OF MDS: All
  2. SEVERITY OF MDS: Low, or low to moderate
  3. NAME OF DRUG: Deferasirox
  4. Aims and benefits: This trial investigates how exactly chelation therapy can affect the health of patients with MDS and iron overload
  5. Main basic inclusion criteria: MDS patients with Transfusional Iron Overload. Age over 18
  6. Main basic exclusion criteria:
  7. Trial sites/locations and name of physician in charge of trial:
  8. More information: https://clinicaltrials.gov/ct2/show/NCT00940602

Please read information and always discuss trial information with your own physician.
Download information

Learn more about clinical trials

Check current MDS clinical trials opened to recruitment in the UK

Free donations by shopping